Side-by-side financials for ARVN and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARVN | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #48 |
| Revenue (latest FY) | $262.60M | - |
| Net income (latest FY) | -$81.00M | - |
| Net margin | -30.8% | - |
| SEC filings | 575 | 1,004 |
Full pages: ARVINAS, INC. and AstraZeneca PLC, or browse the full rankings.